Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications

OBJECTIVE: To evaluate the cost-effectiveness of a genetic testing policy for HNF1A-, HNF4A-, and GCK-MODY in a hypothetical cohort of type 2 diabetic patients 25–40 years old with a MODY prevalence of 2%. RESEARCH DESIGN AND METHODS: We used a simulation model of type 2 diabetes complications based...

Descripción completa

Detalles Bibliográficos
Autores principales: Naylor, Rochelle N., John, Priya M., Winn, Aaron N., Carmody, David, Greeley, Siri Atma W., Philipson, Louis H., Bell, Graeme I., Huang, Elbert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2014
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867988/
https://www.ncbi.nlm.nih.gov/pubmed/24026547
http://dx.doi.org/10.2337/dc13-0410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867988/
https://www.ncbi.nlm.nih.gov/pubmed/24026547
http://dx.doi.org/10.2337/dc13-0410

Ejemplares similares